DeuteRx
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
300 Brickstone Sq Ste 201, Andover, Mass...Phone Number
(978) 662-5287Website
www.deuteria.comRevenue
<$5 MillionIndustry
About DeuteRx
DeuteRx is a virtual biopharmaceutical company established in 2012, dedicated to enhancing racemic drugs for patients. The company has developed a pioneering technique known as Deuterium-Enabled Chiral Switching (DECS), which isolates a single stereoisomer from a mixture of interconverting stereoisomers. This innovative approach aims to stabilize the preferred stereoisomer in existing drugs, thereby reducing side effects and improving efficacy. DeuteRx has applied its technology to various clinical therapies, including the deuterium-stabilized R-stereoisomer of pioglitazone for nonalcoholic steatohepatitis and the deuterium-stabilized S-stereoisomer of lenalidomide.Explore more
SIC Code 28,283NAICS Code 32,325Show moreDeuteRx Org Chart
Compare Similar Companies to DeuteRx
Compare insights from companies similar to DeuteRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DeuteRx Tech Stack
A closer look at the technologies used by DeuteRx
See more technologies
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding DeuteRx
Sign Up For FreeTo access detailed company insights
DeuteRx is a virtual biopharmaceutical company established in 2012, dedicated to enhancing racemic drugs for patients. The company has developed a pioneering technique known as Deuterium-Enabled Chiral Switching (DECS), which isolates a single stereoisomer from a mixture of interconverting stereoisomers. This innovative approach aims to stabilize t... Read More